Viewing Study NCT01529593

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:09 AM
Ignite Modification Date: 2026-05-11 @ 2:13 PM
Study NCT ID: NCT01529593
Status: TERMINATED
Last Update Posted: 2025-03-24
First Post: 2012-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Temsirolimus in Combination With Metformin in Patients With Advanced Cancers
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Cancers View
None Metastatic cancer View
None Tumor response View
None Dose limiting toxicity View
None DLT View
None Maximum tolerated dose View
None MTD View
None Temsirolimus View
None CCI-779 View
None Torisel View
None Metformin View